US2018311248A1PendingUtilityA1
Compounds and compositions for treating chemical warfare agent-induced injuries
Est. expiryMay 14, 2028(~1.8 yrs left)· nominal 20-yr term from priority
Inventors:Jayhong A. Chong
A61P 9/00A61P 25/24A61P 29/00A61P 25/02A61P 25/00A61P 25/14A61P 25/08A61P 25/22A61P 25/20A61P 27/02A61K 31/519A61P 21/00A61K 31/522C07D 487/04A61P 13/12C07D 473/30C07D 471/04A61K 9/0053A61P 1/08A61P 17/00A61K 9/0019A61K 31/4985A61K 31/4188A61K 9/0014A61P 1/00A61P 11/14A61P 11/00A61P 19/00A61P 1/12A61P 1/16A61P 17/02A61K 9/0048
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein.
Claims
exact text as granted — not AI-modified1 - 11 . (canceled)
12 . A method of treating an injury to the skin or respiratory tract resulting from exposure to a chemical warfare agent, the method comprising administering to a subject an effective amount of a compound of Formula (IV), or a salt thereof:
wherein,
each of R 1 and R 2 is independently C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl, each of which is optionally substituted with 1-4 R 5 ;
L is NR 6 SO 2 , SO 2 NR 6 , OC(O)NR 6 , NR 6 C(O)O, NR 6 C(O)NR 6 , NR 6 C(O), C(O)NR 6 , O, C(O), S, S(O), S(O) 2 , NR 6 , CH 2 , cyclyl, aryl, heterocyclyl, or heteroaryl;
R 3 is cyclyl, heterocyclyl, aryl, heteroaryl, each of which is optionally substituted with 1-4 R 7 ;
each R 5 is independently halo, hydroxyl, alkoxy, amino, alkylamino, dialkylamino, cyano, nitro, amido, alkylamido, dialkylamido, thioyl, sulfonyl, cyclyl, heterocyclyl, aryl, or heteroaryl;
each R 6 is independently H, C 1 -C 6 alkyl, arylalkyl, S(O)alkyl, acetyl, amidyl, or S(O)H;
each R 7 is independently C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cyclyl, heterocyclyl, aryl, heteroaryl, halo, hydroxyl, alkoxy, aryloxy, arylalkoxy, amino, akylamino, dialkylamino, thioyl, alkylthioyl, sulfonyl, sulfonamidyl, amido, urea, sulfonylurea, hydroxyl alkoxyl, alkoxy alkoxyl, acyl, nitro, cyano, each of which is independently substituted with 1-3 R8;
each R 8 is independently C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl, halo, hydroxyl, alkoxy, aryloxy, amino, akylamino, dialkylamino, thioyl, sulfonyl, sulfonamidyl, amido, urea, sulfonylurea acyl, nitro, cyano, cyclyl, heterocyclyl, aryl, or heteroaryl;
each of m and n is independently 0, 1, 2, 3, 4, 5, or 6;
each R 9 is independently H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl, halo, hydroxyl, alkoxy, aryloxy, arylalkoxy, amino, akylamino, dialkylamino, thioyl, alkylthioyl, sulfonyl, sulfonamidyl, amido, urea, sulfonylurea, acyl, nitro, cyano, each of which is independently substituted with 1-3 R 8 .
13 . The method of claim 12 , wherein R 1 and R 2 are independently C 1 -C 6 alkyl.
14 . The method of claim 12 , wherein L is C(O)NR 6 and m is 1.
15 . The method of claim 12 , wherein R 3 is heteroaryl, substituted with 1-4 R 7 .
16 . The method of claim 12 , wherein R 7 is aryl optionally substituted by 1-3 R 8 .
17 . The method of claim 12 , wherein n is 0.
18 . The method of claim 12 , wherein the compound is a compound selected from the group consisting of:
19 . The method of claim 12 , wherein the compound is administered orally, via intramuscular injection, or topically.
20 . The method of claim 12 , wherein the chemical warfare agent is tear gas.
21 . The method of claim 12 , wherein the chemical warfare agent is chlorine.
22 . The method of claim 12 , wherein the chemical warfare agent is mustard gas.
23 . The method of claim 12 , wherein the subject is a human.
24 . A method of treating an injury to the skin or respiratory tract resulting from exposure to a chemical warfare agent, the method comprising administering to a subject an effective amount of a compound of Formula (VI), or a salt thereof
wherein,
R 1 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl, each of which is optionally substituted with 1-4 R 5 ;
R 2 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, or cycyl, each of which is optionally substituted with 1-4 R 5 ;
L is NR 6 SO 2 , SO 2 NR 6 , OC(O)NR 6 , NR 6 C(O)O, NR 6 C(O)NR 6 , NR 6 C(O), C(O)NR 6 , O, C(O), S, S(O), S(O) 2 , NR 6 , CH 2 , cyclyl, aryl, heterocyclyl, or heteroaryl;
R 3 is cyclyl, heterocyclyl, aryl, or heteroaryl, each of which is optionally substituted with 1-4 R 7 ;
each R 5 is independently halo, hydroxyl, alkoxy, amino, alkylamino, dialkylamino, cyano, nitro, amido, alkylamido, dialkylamido, thioyl, sulfonyl, cyclyl, heterocyclyl, aryl, or heteroaryl;
each R 6 is independently H, C 1 -C 6 alkyl, arylalkyl, S(O)alkyl, acetyl, amidyl, or S(O)H;
each R 7 is independently C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, cyclyl, heterocyclyl, aryl, heteroaryl, halo, hydroxyl, alkoxy, aryloxy, arylalkoxy, amino, akylamino, dialkylamino, thioyl, alkylthioyl, sulfonyl, sulfonamidyl, amido, urea, sulfonylurea, hydroxyl alkoxyl, alkoxy alkoxyl, acyl, nitro, cyano, each of which is independently substituted with 1-3 R 8 ;
each R 8 is independently C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl, halo, hydroxyl, alkoxy, aryloxy, amino, akylamino, dialkylamino, thioyl, sulfonyl, sulfonamidyl, amido, urea, sulfonylurea acyl, nitro, cyano, cyclyl, heterocyclyl, aryl, or heteroaryl;
each R 9 is independently H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl, halo, hydroxyl, alkoxy, aryloxy, arylalkoxy, amino, akylamino, dialkylamino, thioyl, alkylthioyl, sulfonyl, sulfonamidyl, amido, urea, sulfonylurea, acyl, nitro, cyano, each of which is independently substituted with 1-3 R 8 ;
each m and n are independently 0, 1, 2, 3, 4, 5, or 6.
25 . The method of claim 24 , wherein R 1 and R 2 are independently C 1 -C 6 alkyl.
26 . The method of claim 24 , wherein L is C(O)NR 6 and m is 1.
27 . The method of claim 24 , wherein R 3 is heteroaryl, substituted with 1-4 R 7 .
28 . The method of claim 24 , wherein R 7 is aryl optionally substituted by 1-3 R 8 .
29 . The method of claim 24 , wherein n is 0.
30 . The method of claim 24 , wherein the compound is a compound selected from the group consisting of:
31 . The method of claim 24 , wherein the compound is administered orally, via intramuscular injection, or topically.
32 . The method of claim 24 , wherein the chemical warfare agent is tear gas.
33 . The method of claim 24 , wherein the chemical warfare agent is chlorine.
34 . The method of claim 24 , wherein the chemical warfare agent is mustard gas.
35 . The method of claim 24 , wherein the subject is a human.Join the waitlist — get patent alerts
Track US2018311248A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.